When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BLRX - BioLineRx advances late-stage study of motixafortide
BioLineRx Ltd.
BioLineRx (NASDAQ:BLRX)announces that enough patients have been enrolled in the Phase 3 GENESIS study to allow for an interim efficacy analysis in H2. If the primary endpoint is met, it intends to stop further recruitment and report topline results in H1 2021. If the primary objective is not met, recruitment will continue as planned.
More news on: BioLineRx Ltd., Healthcare stocks news, Stocks on the move,